Xiang Huang
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Genomic profiling and HER2-targeted therapy: a case series of Chinese salivary duct carcinoma patients and its clinical implications.
Journal: Frontiers in oncology
Published: October 17, 2025
Histone deacetylase inhibition enhances extracellular vesicles from muscle to promote osteogenesis via miR-873-3p.
Journal: Signal transduction and targeted therapy
Published: December 21, 2023
Bifidobacterium animalis subsp. lactis A6 ameliorates bone and muscle loss via modulating gut microbiota composition and enhancing butyrate production.
Journal: Bone research
Published: November 17, 2023
The Influences of Cryopreservation Methods on RNA, Protein, Microstructure and Cell Viability of Skeletal Muscle Tissue.
Journal: Biopreservation and biobanking
Published: August 18, 2023
Long-term efficacy and predictors of pembrolizumab-based regimens in patients with advanced esophageal cancer in the real world.
Journal: World journal of gastroenterology
Published: July 27, 2023
Deciphering Immune Landscape Remodeling Unravels the Underlying Mechanism for Synchronized Muscle and Bone Aging.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: June 20, 2023
Multi-Proteomic Analysis Reveals the Effect of Protein Lactylation on Matrix and Cholesterol Metabolism in Tendinopathy.
Journal: Journal of proteome research
Published: May 09, 2023
Biomarkers for immunotherapy in esophageal cancer.
Journal: Frontiers in immunology
Published: December 06, 2022
Targeting GSTP1-dependent ferroptosis in lung cancer radiotherapy: Existing evidence and future directions.
Journal: Frontiers in molecular biosciences
Published: November 18, 2022
Monophosphoryl lipid A ameliorates radiation-induced lung injury by promoting the polarization of macrophages to the M1 phenotype.
Journal: Journal of translational medicine
Published: October 19, 2022
Efficacy and safety of combined treatment with pembrolizumab in patients with locally advanced or metastatic esophageal squamous cell carcinoma in the real world.
Journal: Annals of translational medicine
Published: April 01, 2022
Last Updated: 09/26/2026